Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cell Competition in Carcinogenesis
Esha Madan, Antonio Palma, Vignesh Vudatha, et al.
Cancer Research (2022) Vol. 82, Iss. 24, pp. 4487-4496
Open Access | Times Cited: 25

Showing 25 citing articles:

Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray, In Vitro, In Vivo, and In Silico Investigations of Coumarin-Based Thiazoles
Salma M. Hefny, Tarek F. El‐Moselhy, Nabaweya Sharaf El-Din, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7406-7430
Closed Access | Times Cited: 17
Rationale design of novel substituted 1,3,5-triazine candidates as dual IDH1(R132H)/ IDH2(R140Q) inhibitors with high selectivity against acute myeloid leukemia: In vitro and in vivo preclinical investigations
Haytham O. Tawfik, Mai H. A. Mousa, Mohamed Y. Zaky, et al.
Bioorganic Chemistry (2024) Vol. 149, pp. 107483-107483
Closed Access | Times Cited: 9
Onco-Breastomics: An Eco-Evo-Devo Holistic Approach
Anca-Narcisa Neagu, Danielle Whitham, Pathea Bruno, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1628-1628
Open Access | Times Cited: 4
Exploring chromone‐2‐carboxamide derivatives for triple‐negative breast cancer targeting EGFR, FGFR3, and VEGF pathways: Design, synthesis, and preclinical insights
Dalia S. El‐Gamil, Mohamed Y. Zaky, Patrick M. Maximous, et al.
Drug Development Research (2024) Vol. 85, Iss. 5
Closed Access | Times Cited: 4
Lenvatinib in combination with pembrolizumab as first-line therapy for advanced endometrial cancer: clinical case
E. A. Khachaturyan, Tatiana G. Antonova, O. Stativko, et al.
Tumors of female reproductive system (2025) Vol. 21, Iss. 1, pp. 142-146
Open Access
Road of no return — loss of TP53 paves a defined evolution path from gastric preneoplasia-to-cancer
Liwei An, Yi Han, Shi Jiao, et al.
Cancer Biology and Medicine (2024) Vol. 20, Iss. 12, pp. 885-890
Open Access | Times Cited: 2
A resource-based mechanistic framework for castration-resistant prostate cancer (CRPC)
B. Vibishan, Harshavardhan B.V., Sutirth Dey
Journal of Theoretical Biology (2024) Vol. 587, pp. 111806-111806
Open Access | Times Cited: 2
MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis
Santanu Maji, Anjan K. Pradhan, Amit Kumar, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 45
Open Access | Times Cited: 6
Aneuploidy Landscape in Precursors of Ovarian Cancer
Yeh Wang, Christopher Douville, Yen‐Wei Chien, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 3, pp. 600-615
Closed Access | Times Cited: 6
Differential Ire1 determines loser cell fate in tumor-suppressive cell competition
Jiadong Zheng, Yifan Guo, Changyi Shi, et al.
Cell Reports (2023) Vol. 42, Iss. 11, pp. 113303-113303
Open Access | Times Cited: 5
Growth rate-driven modelling reveals how phenotypic adaptation drives drug resistance in BRAFV600E-mutant melanoma
Sara Hamis, Alexander P. Browning, Adrianne L. Jenner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
A Comprehensive Review of Protein Biomarkers for Invasive Lung Cancer
Alexandre Mezentsev, Mikhail Durymanov, В. А. Макаров
Current Oncology (2024) Vol. 31, Iss. 9, pp. 4818-4854
Open Access | Times Cited: 1
Dissecting the tumor ecosystem of liver cancers in the single-cell era
Yue Wang, Pengxiang Wang, Zefan Zhang, et al.
Hepatology Communications (2023) Vol. 7, Iss. 9
Open Access | Times Cited: 3
Peritumoral SPARC expression induced by exosomes from nasopharyngeal carcinoma infected Epstein‐Barr virus: A poor prognostic marker
Hirotomo Dochi, Satoru Kondo, Shigetaka Komura, et al.
International Journal of Cancer (2023) Vol. 154, Iss. 5, pp. 895-911
Closed Access | Times Cited: 3
Flamingo participates in multiple models of cell competition
Pablo Sanchez Bosch, Bomsoo Cho, Jeffrey D. Axelrod
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Flamingo participates in multiple models of cell competition
Pablo Sanchez Bosch, Bomsoo Cho, Jeffrey D. Axelrod
eLife (2024) Vol. 13
Open Access
Flamingo participates in multiple models of cell competition
Pablo Sanchez Bosch, Bomsoo Cho, Jeffrey D. Axelrod
(2024)
Open Access
Clonal expansion of cancer driver gene mutants investigated using advanced sequencing technologies
Barbara L. Parsons
Mutation Research/Reviews in Mutation Research (2024) Vol. 794, pp. 108514-108514
Open Access
Flamingo participates in multiple models of cell competition
Pablo Sanchez Bosch, Bomsoo Cho, Jeffrey D. Axelrod
(2024)
Open Access
Flamingo participates in multiple models of cell competition
Pablo Sanchez Bosch, Bomsoo Cho, Jeffrey D. Axelrod
(2024)
Open Access
Flamingo participates in multiple models of cell competition
Pablo Sanchez Bosch, Bomsoo Cho, Jeffrey D. Axelrod
eLife (2024) Vol. 13
Open Access
Animal models in biomedical research: relevance of Drosophila melanogaster
Tajudeen Olabisi Obafemi, Ademola Olabode Ayeleso, Olusola Bolaji Adewale, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41605-e41605
Open Access
Cancer evolution as a new target of treatment paradigm
V.A. Chubenko
Practical oncology (2023) Vol. 24, Iss. 1, pp. 33-38
Open Access
Exploring cell competition for the prevention and therapy of esophageal squamous cell carcinoma
Kristen Knapp, Vincent Verchio, Olivia Coburn‐Flynn, et al.
Biochemical Pharmacology (2023) Vol. 214, pp. 115639-115639
Open Access
The winner takes it all: Competition drives clonal selection in gliomagenesis
Frank Winkler
Cancer Cell (2023) Vol. 41, Iss. 8, pp. 1394-1396
Closed Access
Page 1

Scroll to top